Rasagiline
NDC 62135-677, Rasagiline, tablet, from Chartwell RX, LLC.
- Product NDC
- 62135-677
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201892
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-677 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RASAGILINE MESYLATE1 mg/1
Pharmacologic classes
Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-677-30 | 62135067730 | 30 TABLET in 1 BOTTLE (62135-677-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d9168d62-814a-444f-9d70-11674def339dNADAC price for package 62135067730
GET /v1/drugs/nadac/62135067730
Use it
Look up 62135-677 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-677 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-677. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.